Alto Neuroscience, Inc. (ANRO)
22.36
-1.93
(-7.95%)
USD |
NYSE |
Mar 17, 16:00
22.50
+0.14
(+0.63%)
Pre-Market: 20:00
Alto Neuroscience Price to Book Value : 4.596 for March 17, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Halozyme Therapeutics, Inc. | 157.47 |
| Vertex Pharmaceuticals, Inc. | 6.294 |
| Fortress Biotech, Inc. | 1.734 |
| Oramed Pharmaceuticals, Inc. | 0.7068 |
| Replimune Group, Inc. | 2.745 |
Price to Book Value Related Metrics
| Price | 22.36 |
| Earnings Yield | -10.04% |
| Market Cap | 694.64M |